Company profile: Addrenex Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of specialty pharmaceutical drug development focused on creating drugs that regulate the adrenergic system.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Addrenex Pharmaceuticals
MapLight Therapeutics
HQ: United States
Website
- Description: Provider of a discovery platform using optogenetics, STARmap, and transcriptomics to identify neural circuits and develop therapeutics for brain disorders, including ML-004 for Autism Spectrum Disorder (Phase 2), and candidates for schizophrenia (M1/M4 muscarinic), Alzheimer’s disease psychosis, and Parkinson’s disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MapLight Therapeutics company profile →
Allay Therapeutics
HQ: United States
Website
- Description: Provider of analgesic products for post-surgical pain management and recuperation, including ATX-101, which delivers controlled-release bupivacaine at the surgical site to provide weeks of pain relief after total knee replacement. Offers a proprietary technology platform combining non-opioid analgesics and biopolymers to create dissolvable candidates for localized, extended pain relief.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Allay Therapeutics company profile →
Rapport Therapeutics
HQ: United States
Website
- Description: Provider of precision medicines for neurological disorders, leveraging a RAP Technology Platform to discover and develop small-molecule therapies targeting specific neuronal receptor complexes. Programs include TARPγ8 AMPAR small molecules in clinical development for epilepsy with potential in pain and bipolar disorder, and discovery-stage nAChR modulators for chronic pain and hearing disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rapport Therapeutics company profile →
Predix Pharmaceuticals
HQ: United States
Website
- Description: Provider of drug discovery and development leveraging a novel 3D Discovery and Optimization Engine for GPCR drug candidates. Utilizes the proprietary PREDICT algorithm to computer-model the 3D structure of any GPCR target and advance novel compounds into the clinic.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Predix Pharmaceuticals company profile →
Zynex Medical
HQ: United States
Website
- Description: Provider of medical devices of its own design, engineered, manufactured, marketed, and sold by Zynex through three subsidiaries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zynex Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Addrenex Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Addrenex Pharmaceuticals
2.2 - Growth funds investing in similar companies to Addrenex Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Addrenex Pharmaceuticals
4.2 - Public trading comparable groups for Addrenex Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →